PT
● MODULE 16 / 20
Antibacterial Drugs & Stewardship
Match microbial targets, exposure and resistance to a rational antibacterial choice.
Quick revision ↓ Medical Dictionary
FULL CHAPTER EXPLANATION
Deep Learning — Module 16
Read this section in sequence. It moves from drug targets to therapeutic effects, adverse reactions and safe use.
01
Selection and resistance
Selective toxicity exploits differences between bacterial and human biology, but host toxicity remains possible. Empirical treatment uses the likely organism, site, severity and local resistance pattern; culture results can support narrowing or changing therapy. Resistance arises through target alteration, drug inactivation, reduced entry or efflux. Broad spectrum does not automatically mean better treatment. Dose, duration, source control and tissue penetration all contribute to success, and colonization is not automatically an indication for antibiotics.
02
Cell-wall and membrane targets
Beta-lactams bind penicillin-binding proteins and impair peptidoglycan cross-linking. Penicillins, cephalosporins, carbapenems and monobactams differ in spectrum and stability to resistance mechanisms. Beta-lactamase inhibitors protect selected combinations but do not defeat every resistance pathway. Vancomycin binds cell-wall precursors and has predominantly Gram-positive activity. Oral vancomycin mainly acts in the intestinal lumen; it is not a substitute for systemic administration when systemic exposure is needed. Daptomycin disrupts bacterial membranes but is inactivated by pulmonary surfactant.
03
Protein synthesis inhibitors
Aminoglycosides affect the 30S subunit and can cause nephrotoxicity and ototoxicity; their uptake is poor in anaerobic conditions. Tetracyclines also act at 30S and can chelate with polyvalent cations. Macrolides, clindamycin, chloramphenicol and linezolid act at 50S through differing mechanisms. Some macrolides have important enzyme and QT interactions. Clindamycin is associated with C. difficile disease; linezolid has hematologic and serotonergic interaction concerns. A shared ribosomal target does not confer identical spectrum or toxicity.
04
Nucleic acid and folate pathways
Fluoroquinolones inhibit bacterial DNA gyrase or topoisomerase IV and have important tendon, neurological and other safety concerns. Rifamycins inhibit bacterial RNA polymerase. Metronidazole forms reactive products in susceptible anaerobic organisms and protozoa. Sulfonamides and trimethoprim block sequential folate pathway steps; trimethoprim can raise potassium. Pregnancy, renal function, allergy and local susceptibility may change suitability. Antibiotics are not effective treatment for an uncomplicated viral infection simply because fever is present.
05
Practical antimicrobial reasoning
For a suspected infection, define the syndrome, take appropriate specimens without delaying essential urgent treatment, identify likely pathogens and choose an evidence-based regimen. Review microbiology and response, de-escalate when appropriate and set a stop or review date. Sexually transmitted infections require organism-specific testing, partner considerations and current local regimens; resistance makes memorized universal combinations unsafe. Explain adherence and adverse-effect reporting. A culture report is interpreted with the patient, specimen quality and infection site rather than read in isolation.
High-Yield Revision
- Spectrum, site penetration and susceptibility must all fit the infection.
- Narrow therapy when microbiology and clinical response support it.
- Antibiotic-associated diarrhea can represent C. difficile infection.
Common Exam & Concept Pitfalls
- Oral vancomycin is not systemic vancomycin exposure.
- A susceptible laboratory result does not correct poor source control.
Sources & Further Reading
Curriculum scope checked 23 September 2026. These original study notes summarize established principles; current institutional guidance and product information govern clinical use. Faculty review is pending.
RAHBAR study structure: target → drug action → therapeutic use → adverse effects → monitoring. Use institutional curriculum and faculty guidance for local sequencing, practical requirements and assessment specifications.